Specifically, ASA successfully lobbied the Senate Committee on Health, Education, Labor and Pensions to include language in the bill that would require manufacturers to notify the FDA when there is a shortage of a “sterile injectable product” or a drug “used in emergency medical care or during surgery.”
Anesthetic and central nervous system drugs now account for 23 percent of drug shortages nationwide.
Related Articles on Anesthesia:
Stricter Guidelines Needed for Blood Transfusions, Study Says
Anesthesiologist Who Developed Checklist Protocol Receives ABMS Award
Anesthesiologists Are Top Earners in Pennsylvania
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.